Therefore, we hypothesized that genetic variants in the PKN1/FAK/PI3K/AKT pathway were associated with the survival of PC patients, and we tested this hypothesis with a two‐stage survival analysis in a total of 547 subjects. The gene discussed is AKT1; the disease is pachyonychia congenita.